Search company, investor...
Search

Predict your next investment

Private Equity
sdicfund.com

See what CB Insights has to offer

Investments

47

Portfolio Exits

21

Funds

7

About SDIC Innovation Investment Management

SDIC Innovation is an independent professional private equity management institution which manages financial institution funds, social security funds and state-owned and private capital. SDIC Innovation focuses on discovering and creating enterprise value, striving to unify the interests of invested enterprises, existing shareholders and investors.

SDIC Innovation Investment Management Headquarters Location

Guanganmen outside the South Binhe Road on the 7th floor Xicheng District

Beijing, Beijing, 100055,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest SDIC Innovation Investment Management News

Novogene Completes USD $75 Million [515 Million RMB] B Round Financing

Dec 1, 2016

Novogene Completes USD $75 Million [515 Million RMB] B Round Financing SAN DIEGO and BEIJING, November 30, 2016-- Novogene Technology Co., Ltd., a leading commercial provider of genomic services and solutions with cutting edge next-generation sequencing (NGS) and bioinformatics expertise, announced today that it has completed a USD $75 Million [515 Million RMB] B round financing with China Merchants Bank Co., Ltd.'s CMB International Capital Management (Shenzhen) Co., Ltd. ("CMB International"), SDIC Innovation Investment Management Co., Ltd. ("SDIC Innovation") and Shanghai Sigma Square Investment Center LP ("Sigma Square Capital"). Novogene, headquartered in Beijing with the largest genomic sequencing center in the Asia-Pacific region, has labs in Tianjin and the U.S., and subsidiaries or joint ventures in Hong Kong, the U.S. (Novogene Corporation headquartered in San Diego), U.K. and Singapore. In addition to its industry-leading NGS service capabilities, Novogene has established a clinical lab in China that meets US CLIA and CAP standards, where it provides tumor gene detection and genetic testing services to patients, hospitals and pharmaceutical companies in China. The Series B financing will support strategic growth in Novogene's global NGS service market and in clinical sequencing R&D and services. Additionally, funds from the financing will be used to enhance operating efficiency to further strengthen the company's leadership position in the NGS industry. "We welcome the participation of our valued investors and are honored by their support and confidence in the future of our company," stated Novogene CEO Dr. Ruiqiang Li. "Since being founded in 2011, Novogene has rapidly emerged as a global leader in genomics and bioinformatics, pioneering the application of biology, computer science and information technology in animal and plant research as well as human health. This financing will enable us to continue to build on that momentum. " About CMB International CMB International, a wholly-owned subsidiary of China Merchants Bank ("CMB"), provides comprehensive high-quality financial services to institutional and corporate clients as well as individual investors. CMB International acts as the only direct investment platform of CMB, responsible for leveraging the domestic large emerging financial market with domestic and overseas capital. CMB International specializes in private equity investment, investment fund management, mezzanine fund management, cross-border capital operations and other financial services. About SDIC Innovation SDIC Innovation is an independent professional private equity management institution managing 50 billion RMB in assets. SDIC Innovation, which manages financial institution funds, social security funds and state-owned and private capital, is one of the largest professional private equity management institutions [in China]. SDIC innovation, focuses on discovering and creating enterprise value, striving to unify the interests of invested enterprises, existing shareholders and investors. About Sigma Square Capital Founded in 2016, Sigma Square Capital is an investment institution focused on high-growth emerging industries. Sigma Square Capital is an early stage investor in the emerging fields of healthcare, technology, finance and consumer products. The two founding partners, Kun Ouyang and Dai Zhang, have led media, medical and health field investments for many years for IDG Capital. About Novogene Corporation Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and one of the largest sequencing capacities in the world. Novogene utilizes scientific excellence, a commitment to customer service and unsurpassed data quality to help our clients realize their research goals in the rapidly evolving world of genomics. With 1,300 employees, multiple locations around the world, 43 NGS related patents, and over 200 publications in top tier journal such as Nature and Science, the company has rapidly become a world-leader in NGS services. For more information, visit http://en.novogene.com/. Contact: Global Marketing Director and General Manager Novogene Corporation

SDIC Innovation Investment Management Investments

47 Investments

SDIC Innovation Investment Management has made 47 investments. Their latest investment was in Banma Network Technologies as part of their Series B on July 7, 2021.

CBI Logo

SDIC Innovation Investment Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/14/2021

Series B

Banma Network Technologies

$463M

No

11

7/2/2021

Series A

CanSemi

$309.02M

Yes

2

10/30/2020

Series C

Zylox Medical Device

$44.68M

No

3

10/12/2020

Private Equity

Subscribe to see more

$99M

Subscribe to see more

10

7/29/2020

Seed VC - II

Subscribe to see more

Subscribe to see more

10

Date

7/14/2021

7/2/2021

10/30/2020

10/12/2020

7/29/2020

Round

Series B

Series A

Series C

Private Equity

Seed VC - II

Company

Banma Network Technologies

CanSemi

Zylox Medical Device

Subscribe to see more

Subscribe to see more

Amount

$463M

$309.02M

$44.68M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

11

2

3

10

10

SDIC Innovation Investment Management Portfolio Exits

21 Portfolio Exits

SDIC Innovation Investment Management has 21 portfolio exits. Their latest portfolio exit was He's Eye Hospital on March 22, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/22/2022

IPO

$99M

Public

1

2/9/2022

IPO

$99M

Public

1

7/12/2021

IPO

$99M

Public

1

4/13/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

3/2/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/22/2022

2/9/2022

7/12/2021

4/13/2021

3/2/2021

Exit

IPO

IPO

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Public

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

SDIC Innovation Investment Management Fund History

7 Fund Histories

SDIC Innovation Investment Management has 7 funds, including SDIC Chuanghe National Emerging Industry Venture Capital Guiding Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

5/9/2017

SDIC Chuanghe National Emerging Industry Venture Capital Guiding Fund

Fund Of Funds

Closed

$2,589.52M

1

2/6/2017

SDIC Jinjinji Science & Technology Achievement Transformation VC Fund

Subscribe to see more

Subscribe to see more

$99M

10

2/6/2017

SDIC Shanghai Science & Technology Achievement Transformation VC Fund

Subscribe to see more

Subscribe to see more

$99M

10

5/19/2015

CMCC Innovation Industry Fund

Subscribe to see more

Subscribe to see more

$99M

10

11/4/2010

SDIC Cooperation Equity Investment Fund

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

5/9/2017

2/6/2017

2/6/2017

5/19/2015

11/4/2010

Fund

SDIC Chuanghe National Emerging Industry Venture Capital Guiding Fund

SDIC Jinjinji Science & Technology Achievement Transformation VC Fund

SDIC Shanghai Science & Technology Achievement Transformation VC Fund

CMCC Innovation Industry Fund

SDIC Cooperation Equity Investment Fund

Fund Type

Fund Of Funds

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$2,589.52M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

SDIC Innovation Investment Management Team

2 Team Members

SDIC Innovation Investment Management has 2 team members, including current President, Huisheng Wang.

Name

Work History

Title

Status

Huisheng Wang

President

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Huisheng Wang

Subscribe to see more

Work History

Title

President

Subscribe to see more

Status

Current

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.